trending Market Intelligence /marketintelligence/en/news-insights/trending/iaw4z7jmjbi_zsgvzc7dkg2 content esgSubNav
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us
In This List

Catalyst Pharmaceuticals names chief commercial officer

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help


Catalyst Pharmaceuticals names chief commercial officer

Catalyst Pharmaceuticals Inc. appointed Daniel Brennan as chief commercial officer.

Brennan will lead the biopharmaceutical company's marketing, sales and commercial operations. He most recently served as COO at Edge Therapeutics Inc.